These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 23941202)
1. Lithium treatment alleviates impaired cognition in a mouse model of fragile X syndrome. King MK; Jope RS Genes Brain Behav; 2013 Oct; 12(7):723-31. PubMed ID: 23941202 [TBL] [Abstract][Full Text] [Related]
2. Glycogen synthase kinase-3 inhibitors reverse deficits in long-term potentiation and cognition in fragile X mice. Franklin AV; King MK; Palomo V; Martinez A; McMahon LL; Jope RS Biol Psychiatry; 2014 Feb; 75(3):198-206. PubMed ID: 24041505 [TBL] [Abstract][Full Text] [Related]
3. Lithium reverses increased rates of cerebral protein synthesis in a mouse model of fragile X syndrome. Liu ZH; Huang T; Smith CB Neurobiol Dis; 2012 Mar; 45(3):1145-52. PubMed ID: 22227453 [TBL] [Abstract][Full Text] [Related]
4. Cannabidiol (CBD) reduces anxiety-related behavior in mice via an FMRP-independent mechanism. Zieba J; Sinclair D; Sebree T; Bonn-Miller M; Gutterman D; Siegel S; Karl T Pharmacol Biochem Behav; 2019 Jun; 181():93-100. PubMed ID: 31063743 [TBL] [Abstract][Full Text] [Related]
5. GSK3 influences social preference and anxiety-related behaviors during social interaction in a mouse model of fragile X syndrome and autism. Mines MA; Yuskaitis CJ; King MK; Beurel E; Jope RS PLoS One; 2010 Mar; 5(3):e9706. PubMed ID: 20300527 [TBL] [Abstract][Full Text] [Related]
6. Long-lasting effects of minocycline on behavior in young but not adult Fragile X mice. Dansie LE; Phommahaxay K; Okusanya AG; Uwadia J; Huang M; Rotschafer SE; Razak KA; Ethell DW; Ethell IM Neuroscience; 2013 Aug; 246():186-98. PubMed ID: 23660195 [TBL] [Abstract][Full Text] [Related]
7. Cotinine administration improves impaired cognition in the mouse model of Fragile X syndrome. Pardo M; Beurel E; Jope RS Eur J Neurosci; 2017 Feb; 45(4):490-498. PubMed ID: 27775852 [TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome. Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918 [TBL] [Abstract][Full Text] [Related]
9. Reelin central fragment supplementation improves cognitive deficits in a mouse model of Fragile X Syndrome. Morrill NK; Joly-Amado A; Li Q; Prabhudeva S; Weeber EJ; Nash KR Exp Neurol; 2022 Nov; 357():114170. PubMed ID: 35863501 [TBL] [Abstract][Full Text] [Related]
10. Lithium ameliorates phenotypic deficits in a mouse model of fragile X syndrome. Liu ZH; Chuang DM; Smith CB Int J Neuropsychopharmacol; 2011 Jun; 14(5):618-30. PubMed ID: 20497624 [TBL] [Abstract][Full Text] [Related]
11. Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice. Michalon A; Bruns A; Risterucci C; Honer M; Ballard TM; Ozmen L; Jaeschke G; Wettstein JG; von Kienlin M; Künnecke B; Lindemann L Biol Psychiatry; 2014 Feb; 75(3):189-97. PubMed ID: 23910948 [TBL] [Abstract][Full Text] [Related]
12. ICAM5 as a Novel Target for Treating Cognitive Impairment in Fragile X Syndrome. Pei YP; Wang YY; Liu D; Lei HY; Yang ZH; Zhang ZW; Han M; Cheng K; Chen YS; Li JQ; Cheng GR; Xu L; Wu QM; McClintock SM; Yang Y; Zhang Y; Zeng Y J Neurosci; 2020 Feb; 40(6):1355-1365. PubMed ID: 31882402 [TBL] [Abstract][Full Text] [Related]
13. Fragile X mental retardation protein replacement restores hippocampal synaptic function in a mouse model of fragile X syndrome. Zeier Z; Kumar A; Bodhinathan K; Feller JA; Foster TC; Bloom DC Gene Ther; 2009 Sep; 16(9):1122-9. PubMed ID: 19571888 [TBL] [Abstract][Full Text] [Related]
14. Fmr1 knockout mice are impaired in a leverpress escape/avoidance task. Brennan FX; Albeck DS; Paylor R Genes Brain Behav; 2006 Aug; 5(6):467-71. PubMed ID: 16923151 [TBL] [Abstract][Full Text] [Related]
15. The effect of an mGluR5 inhibitor on procedural memory and avoidance discrimination impairments in Fmr1 KO mice. Vinueza Veloz MF; Buijsen RA; Willemsen R; Cupido A; Bosman LW; Koekkoek SK; Potters JW; Oostra BA; De Zeeuw CI Genes Brain Behav; 2012 Apr; 11(3):325-31. PubMed ID: 22257369 [TBL] [Abstract][Full Text] [Related]
16. Sex-specific modulation of early life vocalization and cognition by Fmr1 gene dosage in a mouse model of Fragile X Syndrome. Giua G; Iezzi D; Caceres-Rodriguez A; Strauss B; Chavis P; Manzoni OJ Biol Sex Differ; 2024 Feb; 15(1):18. PubMed ID: 38383408 [TBL] [Abstract][Full Text] [Related]
17. Agmatine relieves behavioral impairments in Fragile X mice model. Jeon SJ; Kwon H; Bae HJ; Gonzales EL; Kim J; Chung HJ; Kim DH; Ryu JH; Shin CY Neuropharmacology; 2022 Nov; 219():109234. PubMed ID: 36057317 [TBL] [Abstract][Full Text] [Related]
18. Impaired cognitive discrimination and discoordination of coupled theta-gamma oscillations in Fmr1 knockout mice. Radwan B; Dvorak D; Fenton AA Neurobiol Dis; 2016 Apr; 88():125-38. PubMed ID: 26792400 [TBL] [Abstract][Full Text] [Related]
20. Sustained correction of hippocampal neurogenic and cognitive deficits after a brief treatment by Nutlin-3 in a mouse model of fragile X syndrome. Javadi S; Li Y; Sheng J; Zhao L; Fu Y; Wang D; Zhao X BMC Med; 2022 May; 20(1):163. PubMed ID: 35549943 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]